Prevention of viral hemorrhagic fever Prevention of viral hemorrhagic fever Prevention of viral hemorrhagic fever is similar for the different viruses. There are a number of different viral hemorrhagic fevers including Ebola virus disease, Lassa fever, Rift valley fever, Marburg virus disease, Crimean-Congo haemorrhagic fever (CCHF) and yellow fever. Lassa, Ebola, Marburg and CCHF can be spread by direct contact with the body fluids of those infected. Thus the content here covers the prevention of Ebola. The use of standard precautions is recommended with all patients in a healthcare environment. This includes a minimum level of standard precautions for use with all people regardless of
Rabbit haemorrhagic disease myxomatosis. FILAVAC has been authorised by the VMD in April 2017 ; it is currently the only vaccine containing both classic and variant strain of VHD virus. New outbreak in Canada reported on Vancouver Island http://www.cbc.ca/news/canada/british-columbia/b-c-issues-warning-to-pet-rabbit-owners-as-virus-spreads-to-lower-mainland-1.4587233 Rabbit haemorrhagic disease Rabbit haemorrhagic disease (RHD), also known as rabbit calicivirus disease (RCD) or viral haemorrhagic disease (VHD), is a highly infectious and often fatal disease that affects wild and domestic rabbits of the species "Oryctolagus cuniculus". The infectious agent responsible for the disease is rabbit haemorrhagic disease virus (RHDV), or rabbit calicivirus (RCV), genus "Lagovirus" of the family Caliciviridae. The virus infects